chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelling and redness at the vaccination site; Swelling and redness at the vaccination site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling and redness at the vaccination site) and VACCINATION SITE ERYTHEMA (Swelling and redness at the vaccination site.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling and redness at the vaccination site) and VACCINATION SITE ERYTHEMA (Swelling and redness at the vaccination site.). At the time of the report, VACCINATION SITE SWELLING (Swelling and redness at the vaccination site) and VACCINATION SITE ERYTHEMA (Swelling and redness at the vaccination site.) outcome was unknown.            No concomitant medication were reported. No treatment information was reported  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My brother's arm hurt for a day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My brother's arm hurt for a day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced PAIN IN EXTREMITY (My brother's arm hurt for a day). At the time of the report, PAIN IN EXTREMITY (My brother's arm hurt for a day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Developed a baseball sized lump in both sides of underarm area; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area). At the time of the report, AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medication were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Erythema, Headache, Mass, Pruritus
Clinical narrative: Lump; Itchy thigh; Red ring around itchy thigh; Diarrhea; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Lump), PRURITUS (Itchy thigh), ERYTHEMA (Red ring around itchy thigh), DIARRHOEA (Diarrhea) and HEADACHE (Severe headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MASS (Lump), PRURITUS (Itchy thigh), ERYTHEMA (Red ring around itchy thigh), DIARRHOEA (Diarrhea) and HEADACHE (Severe headache). At the time of the report, MASS (Lump), PRURITUS (Itchy thigh), ERYTHEMA (Red ring around itchy thigh), DIARRHOEA (Diarrhea) and HEADACHE (Severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had been punctured for 26 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours). On 17-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Terrible rash/ very painful rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Terrible rash/ very painful rash) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included NORTRIPTYLINE for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced RASH (Terrible rash/ very painful rash). The patient was treated with CLOBETASOL for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Terrible rash/ very painful rash) outcome was unknown.            The patients symptoms remained for approximately 3 weeks.   This case was linked to MOD-2021-228443 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Musculoskeletal stiffness, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: Arm  was slightly red; arm  was very painful; Arm  was hard; Arm was a bit swollen; mild general aches; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm  was slightly red), PAIN IN EXTREMITY (arm  was very painful), MUSCULOSKELETAL STIFFNESS (Arm  was hard), PERIPHERAL SWELLING (Arm was a bit swollen) and MYALGIA (mild general aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm  was slightly red), PAIN IN EXTREMITY (arm  was very painful), MUSCULOSKELETAL STIFFNESS (Arm  was hard), PERIPHERAL SWELLING (Arm was a bit swollen) and MYALGIA (mild general aches). At the time of the report, ERYTHEMA (Arm  was slightly red), PAIN IN EXTREMITY (arm  was very painful), MUSCULOSKELETAL STIFFNESS (Arm  was hard), PERIPHERAL SWELLING (Arm was a bit swollen) and MYALGIA (mild general aches) had resolved.            No concomitant medications were reported.   The patient stated that the arm was very painful ,slightly red , hard, maybe a bit swollen and this lasted for 6 to 7 days.  No treatment information was provided.   This case was linked to MOD-2021-022841 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Fever; Aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and MYALGIA (Aches). At the time of the report, PYREXIA (Fever) and MYALGIA (Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported. Treatment Information was not provided by Reporter.
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Thingly sensation in the right arm (vaccination in the left arm).; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Thingly sensation in the right arm (vaccination in the left arm).) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Thingly sensation in the right arm (vaccination in the left arm).). At the time of the report, PARAESTHESIA (Thingly sensation in the right arm (vaccination in the left arm).) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Feeling abnormal, Influenza, Myalgia, Rash macular
Clinical narrative: Red dots under skin/ some of them bleed/ bleeding under my skin; Skin lesions on her arms and chest, torso; some become purple, reddish-purple, red-blue; One of them looks like a blister; Felt achey; The flu and all that; Felt crappy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso) and SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included NORTRIPTYLINE for an unknown indication.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy) and MYALGIA (Felt achey). On an unknown date, the patient experienced RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) and BLISTER (One of them looks like a blister). At the time of the report, INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue), BLISTER (One of them looks like a blister) and MYALGIA (Felt achey) outcome was unknown and SKIN LESION (Skin lesions on her arms and chest, torso) had not resolved.            Treatment medication was not provided.   This case was linked to MOD-2021-228419 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Skin lesion
Clinical narrative: Red dots under skin/ some of them bleed/ bleeding under my skin; Skin lesions on her arms and chest, torso; some become purple, reddish-purple, red-blue; One of them looks like a blister; Felt achey; The flu and all that; Felt crappy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso) and SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included NORTRIPTYLINE for an unknown indication.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy) and MYALGIA (Felt achey). On an unknown date, the patient experienced RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN LESION (Skin lesions on her arms and chest, torso), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue) and BLISTER (One of them looks like a blister). At the time of the report, INFLUENZA (The flu and all that), FEELING ABNORMAL (Felt crappy), RASH MACULAR (Red dots under skin/ some of them bleed/ bleeding under my skin), SKIN DISCOLOURATION (some become purple, reddish-purple, red-blue), BLISTER (One of them looks like a blister) and MYALGIA (Felt achey) outcome was unknown and SKIN LESION (Skin lesions on her arms and chest, torso) had not resolved.            Treatment medication was not provided.   This case was linked to MOD-2021-228419 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: Generalized Body Pain; Sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Generalized Body Pain) and MYALGIA (Sore right injection site arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concomitant products included ABATACEPT (ORENCIA), PREDNISONE, AZITHROMYCIN (AZO), ESTROGENS CONJUGATED (PREMARIN), LISINOPRIL, AMITRIPTYLINE, AMINO ACIDS NOS (PROTINEX) and VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Sore right injection site arm). On 11-Apr-2021, the patient experienced PAIN (Generalized Body Pain). On 05-Apr-2021, MYALGIA (Sore right injection site arm) had resolved. On 15-Apr-2021, PAIN (Generalized Body Pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Inappropriate schedule of product administration
Clinical narrative: "Got Sick"; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS ("Got Sick") and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 011DZ1A) for COVID-19 vaccination.     The patient's past medical history included Diverticulitis. Concurrent medical conditions included Allergy NOS and Hay fever.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS ("Got Sick") and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, ILLNESS ("Got Sick") had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medications were provided.  No concomitant medications were reported     This case was linked to MOD-2021-228482 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant Follow up received on 12-Jul-2021. Recovered adverse events reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: A patient experienced chest palpitations after her first dose; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (A patient experienced chest palpitations after her first dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20K) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PALPITATIONS (A patient experienced chest palpitations after her first dose). On 07-Jan-2021, PALPITATIONS (A patient experienced chest palpitations after her first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient is at day 43 after the first vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is at day 43 after the first vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is at day 43 after the first vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is at day 43 after the first vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   On day 43 of receiving 1st dose Nurse practitioner asked if it is ok to give the patient his second dose today, or do they need to restart the vaccine series. No concomitant medications were mentioned. No treatment details were reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Polymenorrhoea
Clinical narrative: A patient experienced mensuration cycle twice in one month after taking second dose; A patient experienced swollen lymph nodes on left side of her breast after taking second dose; A patient experienced muscle ache after taking second dose; This spontaneous case was reported by a consumer and describes the occurrence of POLYMENORRHOEA (A patient experienced mensuration cycle twice in one month after taking second dose), LYMPHADENOPATHY (A patient experienced swollen lymph nodes on left side of her breast after taking second dose) and MYALGIA (A patient experienced muscle ache after taking second dose) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20K) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Feb-2021, the patient experienced POLYMENORRHOEA (A patient experienced mensuration cycle twice in one month after taking second dose), LYMPHADENOPATHY (A patient experienced swollen lymph nodes on left side of her breast after taking second dose) and MYALGIA (A patient experienced muscle ache after taking second dose). At the time of the report, POLYMENORRHOEA (A patient experienced mensuration cycle twice in one month after taking second dose), LYMPHADENOPATHY (A patient experienced swollen lymph nodes on left side of her breast after taking second dose) and MYALGIA (A patient experienced muscle ache after taking second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.     This case was linked to MOD-2021-228449 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vials were administered to several patients after 4-5 days past the 30-day storage mark; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vials were administered to several patients after 4-5 days past the 30-day storage mark) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vials were administered to several patients after 4-5 days past the 30-day storage mark). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vials were administered to several patients after 4-5 days past the 30-day storage mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: No significant information was received.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Just had a fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Just had a fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Just had a fever). At the time of the report, PYREXIA (Just had a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications was provided by the reporter.  No Treatment medications was provided by the reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Micturition urgency
Clinical narrative: weak; had to keep getting up to urinate; she felt exhausted; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), MICTURITION URGENCY (had to keep getting up to urinate) and FATIGUE (she felt exhausted) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 038C21A) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced ASTHENIA (weak), MICTURITION URGENCY (had to keep getting up to urinate) and FATIGUE (she felt exhausted). On 20-May-2021, ASTHENIA (weak), MICTURITION URGENCY (had to keep getting up to urinate) and FATIGUE (she felt exhausted) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. treatment included Juice.   This case was linked to MOD-2021-228477 (Patient Link).
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had been punctured for 26 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Pain, Pruritus
Clinical narrative: Rib pain; Itchy every where; Pin needle pain near breast; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Antibody test negative
Clinical narrative: Antibody test result came back negative; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (Antibody test result came back negative) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (Antibody test result came back negative). At the time of the report, ANTIBODY TEST NEGATIVE (Antibody test result came back negative) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Antibody test: Negative. On 10-Jun-2021, Antibody test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Asthenia, Dry throat, Fatigue, Limb discomfort
Clinical narrative: worsening of arthritis; arms and legs hurt all the time now and that wasn't the case prior to the vaccine; Has a difficult time lifting arm still.; Exhausted; Felt weak; Dry throat; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak), DRY THROAT (Dry throat), ARTHRITIS (worsening of arthritis; arms and legs hurt all the time now and that wasn't the case prior to the vaccine), LIMB DISCOMFORT (Has a difficult time lifting arm still.) and FATIGUE (Exhausted) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 038C21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jun-2021, the patient experienced ASTHENIA (Felt weak), DRY THROAT (Dry throat) and FATIGUE (Exhausted). On an unknown date, the patient experienced ARTHRITIS (worsening of arthritis; arms and legs hurt all the time now and that wasn't the case prior to the vaccine) and LIMB DISCOMFORT (Has a difficult time lifting arm still.). On 17-Jun-2021, ASTHENIA (Felt weak), DRY THROAT (Dry throat) and FATIGUE (Exhausted) had resolved. At the time of the report, ARTHRITIS (worsening of arthritis; arms and legs hurt all the time now and that wasn't the case prior to the vaccine) and LIMB DISCOMFORT (Has a difficult time lifting arm still.) outcome was unknown. Not Provided          Concomitant medications also included multiple unspecified medications for underlying conditions.  Patient reported to have taken juice as treatment a day after the onset of events after which she felt the events resolved.   This case was linked to MOD-2021-228462 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Added 2 new events.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not reported.  Treatment Information was not reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Inappropriate schedule of product administration, Mobility decreased, Pain in extremity
Clinical narrative: she fell asleep; sick; Didn't receive the 2nd dose 1 month after the 1st (>35 days); Head Hurt; arms hurt/Legs Hurt; but felt as if she couldn't get up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up), SOMNOLENCE (she fell asleep), ILLNESS (sick) and HEADACHE (Head Hurt) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011DZ1A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up) and HEADACHE (Head Hurt). On an unknown date, the patient experienced SOMNOLENCE (she fell asleep), ILLNESS (sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Didn't receive the 2nd dose 1 month after the 1st (>35 days)). On 15-Jun-2021, PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up) and HEADACHE (Head Hurt) had resolved. At the time of the report, SOMNOLENCE (she fell asleep), ILLNESS (sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Didn't receive the 2nd dose 1 month after the 1st (>35 days)) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No concomitatnt medication was mentioned. No treatment medication was mentioned.   This case was linked to MOD-2021-228448 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: she fell asleep; sick; Didn't receive the 2nd dose 1 month after the 1st (>35 days); Head Hurt; arms hurt/Legs Hurt; but felt as if she couldn't get up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up), SOMNOLENCE (she fell asleep), ILLNESS (sick) and HEADACHE (Head Hurt) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011DZ1A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up) and HEADACHE (Head Hurt). On an unknown date, the patient experienced SOMNOLENCE (she fell asleep), ILLNESS (sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Didn't receive the 2nd dose 1 month after the 1st (>35 days)). On 15-Jun-2021, PAIN IN EXTREMITY (arms hurt/Legs Hurt), MOBILITY DECREASED (but felt as if she couldn't get up) and HEADACHE (Head Hurt) had resolved. At the time of the report, SOMNOLENCE (she fell asleep), ILLNESS (sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Didn't receive the 2nd dose 1 month after the 1st (>35 days)) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No concomitatnt medication was mentioned. No treatment medication was mentioned.   This case was linked to MOD-2021-228448 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Product dose omission issue, Vaccination complication
Clinical narrative: had 1st dose almost 6 months ago; did not feel good about it; headache; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (had 1st dose almost 6 months ago), VACCINATION COMPLICATION (did not feel good about it) and HEADACHE (headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hypercholesteremia. Concomitant products included ATORVASTATIN for Cholesterol, VALSARTAN for Hypertension.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Dec-2020, the patient experienced VACCINATION COMPLICATION (did not feel good about it) and HEADACHE (headache). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (had 1st dose almost 6 months ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (had 1st dose almost 6 months ago) had resolved and VACCINATION COMPLICATION (did not feel good about it) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported. Patient had high anxiety getting the 2nd dose so missed to get the 2nd shot.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Body temperature, Chest discomfort, Chills, Fatigue
Clinical narrative: I woke up with no voice; runny nose; sore throat; nasal congestion / chest congestion; chest congestion.; chills; was really tired, but couldn't fall asleep; my arm was sore at injection site; I had body pain; fever/ fever of 100.4°F (my normal is 98.5°F); but couldn't fall asleep; I was feeling like I'm on a ride at when I stood up.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (nasal congestion / chest congestion) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced FEELING ABNORMAL (I was feeling like I'm on a ride when I stood up.), INSOMNIA (but couldn't fall asleep), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)). On 17-Jun-2021, the patient experienced APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion) and CHEST DISCOMFORT (chest congestion.). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jun-2021 for Cold, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion), INSOMNIA (but couldn't fall asleep), CHEST DISCOMFORT (chest congestion.), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 degree Celsius Patient normal is 98.5°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia, Myalgia, Nasal congestion, Oropharyngeal pain
Clinical narrative: I woke up with no voice; runny nose; sore throat; nasal congestion / chest congestion; chest congestion.; chills; was really tired, but couldn't fall asleep; my arm was sore at injection site; I had body pain; fever/ fever of 100.4°F (my normal is 98.5°F); but couldn't fall asleep; I was feeling like I'm on a ride at when I stood up.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (nasal congestion / chest congestion) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced FEELING ABNORMAL (I was feeling like I'm on a ride when I stood up.), INSOMNIA (but couldn't fall asleep), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)). On 17-Jun-2021, the patient experienced APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion) and CHEST DISCOMFORT (chest congestion.). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jun-2021 for Cold, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion), INSOMNIA (but couldn't fall asleep), CHEST DISCOMFORT (chest congestion.), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 degree Celsius Patient normal is 98.5°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, Vaccination site pain
Clinical narrative: I woke up with no voice; runny nose; sore throat; nasal congestion / chest congestion; chest congestion.; chills; was really tired, but couldn't fall asleep; my arm was sore at injection site; I had body pain; fever/ fever of 100.4°F (my normal is 98.5°F); but couldn't fall asleep; I was feeling like I'm on a ride at when I stood up.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (nasal congestion / chest congestion) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced FEELING ABNORMAL (I was feeling like I'm on a ride when I stood up.), INSOMNIA (but couldn't fall asleep), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)). On 17-Jun-2021, the patient experienced APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion) and CHEST DISCOMFORT (chest congestion.). The patient was treated with PARACETAMOL (TYLENOL) on 18-Jun-2021 for Cold, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (I was feeling like I'm on a ride at Disney when I stood up.), APHONIA (I woke up with no voice), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (nasal congestion / chest congestion), INSOMNIA (but couldn't fall asleep), CHEST DISCOMFORT (chest congestion.), CHILLS (chills), FATIGUE (was really tired, but couldn't fall asleep), VACCINATION SITE PAIN (my arm was sore at injection site), MYALGIA (I had body pain) and PYREXIA (fever/ fever of 100.4°F (my normal is 98.5°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 degree Celsius Patient normal is 98.5°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Type 1 Diabetes has gotten better/ Need for mealtime insulin has decreased; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Type 1 Diabetes has gotten better/ Need for mealtime insulin has decreased) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus and BPH. Concomitant products included TADALAFIL (CIALIS) for BPH, INSULIN DETEMIR (LEVEMIR) and INSULIN ASPART (NOVOLOG) for Type 1 diabetes mellitus, EPLERENONE, LEVOTHYROXINE SODIUM (SYNTHROID) and AMLODIPINE BESILATE, BENAZEPRIL HYDROCHLORIDE (LOTREL [AMLODIPINE BESILATE;BENAZEPRIL HYDROCHLORIDE]) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Type 1 Diabetes has gotten better/ Need for mealtime insulin has decreased). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Type 1 Diabetes has gotten better/ Need for mealtime insulin has decreased) outcome was unknown.            No treatment medication information was provided   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21-Jun-2021 included Added E-Mail, Concomitant medication On 19-Jul-2021: Non-significant follow up was received does not contains any new information